PRCM
WX

Pine River Capital Management’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Pine River Capital Management’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-2,039,192
Closed -$88.1M – 816
2015
Q3 		$88.1M Buy
2,039,192
+1,917,828
+1,580% +$80.9M 1.13% 13
2015
Q2 		$5.13M Buy
+121,364
New +$5.12M 0.06% 223
2015
Q1 		– Sell
-29,300
Closed -$987K – 861
2014
Q4 		$987K Sell
29,300
-2,700
-8% -$95.4K 0.01% 536
2014
Q3 		$1.12M Hold
32,000
– – 0.01% 600
2014
Q2 		$1.05M Buy
32,000
+10,800
+51% +$370K 0.02% 530
2014
Q1 		$781K Buy
21,200
+11,700
+123% +$429K 0.01% 455
2013
Q4 		$365K Buy
9,500
+1,300
+16% +$41K ﹤0.01% 586
2013
Q3 		$225K Sell
8,200
-1,900
-19% -$45K ﹤0.01% 459
2013
Q2 		$212K Buy
+10,100
New +$197K ﹤0.01% 434

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Pine River Capital Management's WX Position: Q4 2015 in Review

Pine River Capital Management sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 2,039,192 shares — an estimated $88.1M sold.

Pine River Capital Management first reported a position in WX in Q2 2013 and held it in 9 quarters. The position peaked at $88.1M in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • Pine River Capital Management reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • Pine River Capital Management sold 2,039,192 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $88.1M.
  • Pine River Capital Management first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 9 quarters.
  • Pine River Capital Management's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $88.1M in Q3 2015.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Pine River Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.